{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:16:21Z","timestamp":1788448581520,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018275","name":"American Association of Hip and Knee Surgeons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009283","name":"Orthopaedic Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Orthopedic Clinics of North America"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ocl.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:40:39Z","timestamp":1782333639000},"page":"289-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Osteoarthritis as a Whole-Joint Disease, Part II: Emerging Nociceptive, Metabolic, Senescence, and Regenerative Therapeutic Targets, with Perspectives on Precision Care"],"prefix":"10.1016","volume":"57","author":[{"given":"Shlok V.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Derwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneel S.","family":"Apte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas S.","family":"Piuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ocl.2026.05.002_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7812\/TPP\/17-084","article-title":"Hip osteoarthritis: a primer","volume":"22","author":"Lespasio","year":"2018","journal-title":"Perm J"},{"key":"10.1016\/j.ocl.2026.05.002_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7812\/TPP\/16-183","article-title":"Knee osteoarthritis: a primer","volume":"21","author":"Lespasio","year":"2017","journal-title":"Perm J"},{"issue":"24","key":"10.1016\/j.ocl.2026.05.002_bib3","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1001\/jama.2016.16885","article-title":"US spending on personal health care and public health, 1996-2013","volume":"316","author":"Dieleman","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ocl.2026.05.002_bib4","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","article-title":"Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the global burden of disease study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"10.1016\/j.ocl.2026.05.002_bib5","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"10182","key":"10.1016\/j.ocl.2026.05.002_bib6","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ocl.2026.05.002_bib7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s12276-021-00710-y","article-title":"Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions","volume":"53","author":"Cho","year":"2021","journal-title":"Exp Mol Med"},{"issue":"2","key":"10.1016\/j.ocl.2026.05.002_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/acr.24131","article-title":"2019 American college of rheumatology\/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee","volume":"72","author":"Kolasinski","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ocl.2026.05.002_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bcp.2019.02.037","article-title":"Osteoarthritis phenotypes and novel therapeutic targets","volume":"165","author":"Van Spil","year":"2019","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.ocl.2026.05.002_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13020355","article-title":"Advances and challenges in the pursuit of disease-modifying osteoarthritis drugs: a review of 2010\u20132024 clinical trials","volume":"13","author":"Brandt","year":"2025","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.ocl.2026.05.002_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41584-024-01126-4","article-title":"Clinical phenotypes, molecular endotypes and theratypes in OA therapeutic development","volume":"20","author":"Mobasheri","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ocl.2026.05.002_bib12","article-title":"Deconvoluting synovial fluid molecular endotypes in knee osteoarthritis: primary results from the STEpUP OA consortium","author":"Perry","year":"2024","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.ocl.2026.05.002_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/19476035221074003","article-title":"Assessment of clinical, tissue, and cell-level metrics identify four biologically distinct knee osteoarthritis patient phenotypes","volume":"13","author":"Mantripragada","year":"2022","journal-title":"Cartilage"},{"key":"10.1016\/j.ocl.2026.05.002_bib14","series-title":"Lilly, Pfizer stop development of osteoarthritis drug after FDA rejection, extending bleak run for NGF inhibitors","author":"Taylor","year":"2021"},{"issue":"6","key":"10.1016\/j.ocl.2026.05.002_bib15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/annrheumdis-2019-216296","article-title":"Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period","volume":"79","author":"Berenbaum","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ocl.2026.05.002_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X231171768","article-title":"Role of imaging for eligibility and safety of a-NGF clinical trials","volume":"15","author":"Roemer","year":"2023","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"11","key":"10.1016\/j.ocl.2026.05.002_bib17","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.41012","article-title":"The efficacy, tolerability, and joint safety of fasinumab in osteoarthritis pain: a phase IIb\/III double-blind, placebo-controlled, randomized clinical trial","volume":"71","author":"Dakin","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.ocl.2026.05.002_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2024.100533","article-title":"A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip","volume":"6","author":"DiMartino","year":"2024","journal-title":"Osteoarthr Cartil Open"},{"issue":"9","key":"10.1016\/j.ocl.2026.05.002_bib19","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/art.40894","article-title":"Randomized, double blind, placebo controlled trial of intraarticular trans capsaicin for pain associated with osteoarthritis of the knee","volume":"71","author":"Stevens","year":"2019","journal-title":"Arthritis Rheumatol Hoboken Nj"},{"issue":"1","key":"10.1016\/j.ocl.2026.05.002_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1533-2500.2010.00401.x","article-title":"A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee","volume":"11","author":"Chappell","year":"2011","journal-title":"Pain Pract"},{"issue":"4","key":"10.1016\/j.ocl.2026.05.002_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/pm\/pnaf140","article-title":"Efficacy and safety of genicular nerve ablation techniques for knee osteoarthritis: a systematic review and meta-analysis of Sham-controlled randomized trials","volume":"27","author":"Barreto","year":"2026","journal-title":"Pain Med"},{"issue":"12","key":"10.1016\/j.ocl.2026.05.002_bib22","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jama.2013.277669","article-title":"Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and Obese adults with knee osteoarthritis: the IDEA randomized clinical trial","volume":"310","author":"Messier","year":"2013","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.ocl.2026.05.002_bib23","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa2403664","article-title":"Once-weekly semaglutide in persons with obesity and knee osteoarthritis","volume":"391","author":"Bliddal","year":"2024","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ocl.2026.05.002_bib24","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1001\/jama.2025.3471","article-title":"Metformin for knee osteoarthritis in patients with overweight or obesity: a randomized clinical trial","volume":"333","author":"Pan","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ocl.2026.05.002_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.645842","article-title":"New trends in pharmacological treatments for osteoarthritis","volume":"12","author":"Cai","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ocl.2026.05.002_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.52198\/23.STI.43.OS1736","article-title":"What is the efficacy of intra-articular platelet-rich plasma injections for knee osteoarthritis in clinical practice? A \u201cReal-Life\u201d prospective cohort","volume":"43","author":"Oliveira","year":"2023","journal-title":"Surg Technol Int"},{"key":"10.1016\/j.ocl.2026.05.002_bib29","first-page":"3","article-title":"From platelet-rich plasma to mesenchymal stem cells: cartilage, tendon, and bone regeneration with orthobiologics","volume":"73","author":"Leal","year":"2024","journal-title":"Instr Course Lect"},{"issue":"18","key":"10.1016\/j.ocl.2026.05.002_bib30","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.19.01446","article-title":"The cost-effectiveness of platelet-rich plasma injections for knee osteoarthritis: a markov decision analysis","volume":"102","author":"Rajan","year":"2020","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.ocl.2026.05.002_bib31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MS9.0000000000001615","article-title":"Comparative effectiveness of intra-articular therapies in knee osteoarthritis: a meta-analysis comparing platelet-rich plasma (PRP) with other treatment modalities","volume":"86","author":"Khalid","year":"2023","journal-title":"Ann Med Surg"},{"issue":"7","key":"10.1016\/j.ocl.2026.05.002_bib32","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1007\/s00402-022-04637-5","article-title":"Are leukocyte-poor or multiple injections of platelet-rich plasma more effective than hyaluronic acid for knee osteoarthritis? A systematic review and meta-analysis of randomized controlled trials","volume":"143","author":"Kim","year":"2023","journal-title":"Arch Orthop Trauma Surg"},{"issue":"20","key":"10.1016\/j.ocl.2026.05.002_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2021.19415","article-title":"Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis","volume":"326","author":"Bennell","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ocl.2026.05.002_bib34","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.arthro.2021.11.005","article-title":"Platelet-rich plasma versus hyaluronic acid for hip osteoarthritis yields similarly beneficial short-term clinical outcomes: a systematic review and meta-analysis of level I and II randomized controlled trials","volume":"38","author":"Belk","year":"2022","journal-title":"Arthrosc J Arthrosc Relat Surg"},{"key":"10.1016\/j.ocl.2026.05.002_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1523027","article-title":"Recent advances in the management of knee osteoarthritis: a narrative review","volume":"12","author":"Shtroblia","year":"2025","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.ocl.2026.05.002_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1759720X17752038","article-title":"Intra-articular hyaluronan injections for the treatment of osteoarthritis: perspective for the mechanism of action","volume":"10","author":"Piuzzi","year":"2018","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"10.1016\/j.ocl.2026.05.002_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.semarthrit.2018.01.009","article-title":"Efficacy and safety of repeated courses of hyaluronic acid injections for knee osteoarthritis: a systematic review","volume":"48","author":"Altman","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ocl.2026.05.002_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/2325967119897909","article-title":"Hyaluronic acid injections or oral nonsteroidal anti-inflammatory drugs for knee osteoarthritis: systematic review and meta-analysis of randomized trials","volume":"8","author":"Miller","year":"2020","journal-title":"Orthop J Sports Med"},{"key":"10.1016\/j.ocl.2026.05.002_bib39","doi-asserted-by":"crossref","first-page":"S503","DOI":"10.1016\/j.joca.2019.02.568","article-title":"High molecular weight intraarticular hyaluronic acid for the treatment of knee osteoarthritis: network meta-analysis","volume":"27","author":"Hummer","year":"2019","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"10.1016\/j.ocl.2026.05.002_bib40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00590-025-04292-7","article-title":"Intra-articular hyaluronic acid injections for hip osteoarthritis: a level I systematic review","volume":"35","author":"Migliorini","year":"2025","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"10.1016\/j.ocl.2026.05.002_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.matbio.2014.08.008","article-title":"The biology of lubricin: near frictionless joint motion","volume":"39","author":"Jay","year":"2014","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"issue":"8","key":"10.1016\/j.ocl.2026.05.002_bib42","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/art.27550","article-title":"Prevention of cartilage degeneration and restoration of chondroprotection by lubricin tribosupplementation in the rat following anterior cruciate ligament transection","volume":"62","author":"Jay","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ocl.2026.05.002_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.joca.2014.09.006","article-title":"The impact of early intra-articular administration of interleukin-1 receptor antagonist on lubricin metabolism and cartilage degeneration in an anterior cruciate ligament transection model","volume":"23","author":"Elsaid","year":"2015","journal-title":"Osteoarthr Cartil"},{"issue":"7","key":"10.1016\/j.ocl.2026.05.002_bib44","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1177\/0363546516686965","article-title":"Intra-articular recombinant human proteoglycan 4 mitigates cartilage damage after destabilization of the medial meniscus in the Yucatan minipig","volume":"45","author":"Waller","year":"2017","journal-title":"Am J Sports Med"},{"issue":"19","key":"10.1016\/j.ocl.2026.05.002_bib45","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.3390\/ijms26199305","article-title":"Intra-articular administration of recombinant human proteoglycan 4 (rhPRG4) as a potential therapy for temporomandibular joint osteoarthritis: a preclinical histopathological study","volume":"26","author":"Iturriaga","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ocl.2026.05.002_bib46","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.3928\/01477447-20190118-04","article-title":"Accelerated growth of cellular therapy trials in musculoskeletal disorders: an analysis of the NIH clinical trials data bank","volume":"42","author":"Piuzzi","year":"2019","journal-title":"Orthopedics"},{"issue":"49","key":"10.1016\/j.ocl.2026.05.002_bib47","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023343","article-title":"Efficacy and safety of intra-articular injection of mesenchymal stem cells in the treatment of knee osteoarthritis: a systematic review and meta-analysis","volume":"99","author":"Ma","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"11","key":"10.1016\/j.ocl.2026.05.002_bib48","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1177\/0363546519892278","article-title":"Intra-articular injection of culture-expanded mesenchymal stem cells without adjuvant surgery in knee osteoarthritis: a systematic review and meta-analysis","volume":"48","author":"Kim","year":"2020","journal-title":"Am J Sports Med"},{"issue":"7","key":"10.1016\/j.ocl.2026.05.002_bib49","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00402-019-03140-8","article-title":"Intra-articular injection of mesenchymal stem cells for clinical outcomes and cartilage repair in osteoarthritis of the knee: a meta-analysis of randomized controlled trials","volume":"139","author":"Kim","year":"2019","journal-title":"Arch Orthop Trauma Surg"},{"issue":"8","key":"10.1016\/j.ocl.2026.05.002_bib50","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00590-024-04089-0","article-title":"Management of hip osteoarthritis: harnessing the potential of mesenchymal stem cells-a systematic review","volume":"34","author":"Giorgino","year":"2024","journal-title":"Eur J Orthop Surg Traumatol Orthop Traumatol"},{"issue":"9","key":"10.1016\/j.ocl.2026.05.002_bib51","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2217\/rme-2023-0071","article-title":"Current evidence on mesenchymal stem cells for hip osteoarthritis: a narrative review","volume":"18","author":"Entessari","year":"2023","journal-title":"Regen Med"},{"issue":"18","key":"10.1016\/j.ocl.2026.05.002_bib52","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2106\/JBJS.15.01495","article-title":"Intra-articular cellular therapy for osteoarthritis and focal cartilage defects of the knee: a systematic review of the literature and study quality analysis","volume":"98","author":"Chahla","year":"2016","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.ocl.2026.05.002_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0037-1608844","article-title":"Bone marrow cellular therapies: novel therapy for knee osteoarthritis","volume":"31","author":"Piuzzi","year":"2018","journal-title":"J Knee Surg"},{"issue":"2","key":"10.1016\/j.ocl.2026.05.002_bib54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1302\/0301-620X.102B2.BJJ-2019-1104.R1","article-title":"Rogue stem cell clinics","volume":"102-B","author":"Murray","year":"2020","journal-title":"Bone Jt J"},{"issue":"2","key":"10.1016\/j.ocl.2026.05.002_bib55","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.5435\/JAAOS-D-18-00305","article-title":"Optimizing clinical use of biologics in orthopaedic surgery: consensus recommendations from the 2018 AAOS\/NIH U-13 conference","volume":"27","author":"Chu","year":"2019","journal-title":"J Am Acad Orthop Surg"},{"issue":"4","key":"10.1016\/j.ocl.2026.05.002_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12178-020-09647-7","article-title":"Ethical and practical considerations for integrating cellular (\u201cstem cell\u201d) therapy into clinical practice","volume":"13","author":"Piuzzi","year":"2020","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"3","key":"10.1016\/j.ocl.2026.05.002_bib57","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.arth.2019.10.013","article-title":"Analysis of readability, quality, and content of online information available for \u201cStem Cell\u201d injections for knee osteoarthritis","volume":"35","author":"Ng","year":"2020","journal-title":"J Arthroplast"},{"issue":"8","key":"10.1016\/j.ocl.2026.05.002_bib58","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2106\/JBJS.17.00154","article-title":"Effects of a single intra-articular injection of a microsphere formulation of triamcinolone acetonide on knee osteoarthritis pain","volume":"100","author":"Conaghan","year":"2018","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.ocl.2026.05.002_bib59","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/10717544.2022.2048130","article-title":"Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage","volume":"29","author":"Huang","year":"2022","journal-title":"Drug Deliv"},{"issue":"801","key":"10.1016\/j.ocl.2026.05.002_bib60","doi-asserted-by":"crossref","first-page":"eadu9804","DOI":"10.1126\/scitranslmed.adu9804","article-title":"A phase 1 clinical trial shows safe, sustained, AAV-mediated expression of IL-1Ra in the human osteoarthritic knee joint","volume":"17","author":"De la Vega","year":"2025","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.ocl.2026.05.002_bib61","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/annrheumdis-2020-219760","article-title":"Linking chondrocyte and synovial transcriptional profile to clinical phenotype in osteoarthritis","volume":"80","author":"Steinberg","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ocl.2026.05.002_bib62","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.joca.2024.09.002","article-title":"Degradomics defines proteolysis information flow from human knee osteoarthritis cartilage to matched synovial fluid and the contributions of secreted proteases ADAMTS5, MMP13 and CMA1 to articular cartilage breakdown","volume":"33","author":"Bhutada","year":"2025","journal-title":"Osteoarthr Cartil"},{"issue":"8","key":"10.1016\/j.ocl.2026.05.002_bib63","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.joca.2022.02.622","article-title":"Forward and reverse degradomics defines the proteolytic landscape of human knee osteoarthritic cartilage and the role of the serine protease HtrA1","volume":"30","author":"Bhutada","year":"2022","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.ocl.2026.05.002_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103545","article-title":"Shared decision making using digital twins in knee osteoarthritis care: a randomized clinical trial of an AI-enabled decision aid versus education alone on decision quality, physical function, and user experience","volume":"89","author":"Jayakumar","year":"2025","journal-title":"eClinicalMedicine"},{"issue":"4","key":"10.1016\/j.ocl.2026.05.002_bib65","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2471\/BLT.25.294300","article-title":"A call for inclusion of arthroplasty as essential surgery","volume":"104","author":"Delaney","year":"2026","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.ocl.2026.05.002_bib66","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.3928\/01477447-20250625-01","article-title":"Comparison of industry and national institutes of health funding for orthopedic surgery research","volume":"48","author":"Ng","year":"2025","journal-title":"Orthopedics"},{"issue":"6","key":"10.1016\/j.ocl.2026.05.002_bib67","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2106\/JBJS.22.00693","article-title":"A call to action for musculoskeletal research funding: the growing economic and disease burden of musculoskeletal conditions in the United States is not reflected in musculoskeletal research funding","volume":"105","author":"McConaghy","year":"2023","journal-title":"J Bone Joint Surg Am"},{"issue":"7","key":"10.1016\/j.ocl.2026.05.002_bib68","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/jor.26082","article-title":"Pain assessment in osteoarthritis: present practices and future prospects including the use of biomarkers and wearable technologies, and AI-Driven personalized medicine","volume":"43","author":"Khan","year":"2025","journal-title":"J Orthop Res"}],"container-title":["Orthopedic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030589826000726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030589826000726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:30:35Z","timestamp":1788445835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030589826000726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0030589826000726"],"URL":"https:\/\/doi.org\/10.1016\/j.ocl.2026.05.002","relation":{},"ISSN":["0030-5898"],"issn-type":[{"value":"0030-5898","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoarthritis as a Whole-Joint Disease, Part II: Emerging Nociceptive, Metabolic, Senescence, and Regenerative Therapeutic Targets, with Perspectives on Precision Care","name":"articletitle","label":"Article Title"},{"value":"Orthopedic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ocl.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}